Evaluating the Impact of Psoriasis on Quality of Life: A Cross-Sectional Study in Al Nasiriya, Thi-Qar, Iraq

Suha Nadem Muhsin; Amena Lafeta Muttlaq Al-Shareefi; Rasha Ali Akar

doi:10.17605/cajmns.v6i1.2697

Suha Nadem Muhsin Departments of Pharmacognosy, College of Pharmacy, University of Thi-qar, Thi-qar, 64001, Iraq
Amena Lafeta Muttlaq Al-Shareefi Departments of Pharmacognosy, College of Pharmacy, University of Thi-qar, Thi-qar, 64001, Iraq
Rasha Ali Akar Departments of Pharmaceutical sciences, College of Pharmacy, University of Thi-qar, Thi-qar, 64001, Iraq

DOI: https://doi.org/10.17605/cajmns.v6i1.2697

Keywords: Psoriasis, Quality of life, WHOQOL-BREF questionnaire, Age, Thi-Qar

Abstract

Psoriasis is a lifelong inflammatory skin illness that may have an new Serious Consequences on a patient’s quality of life. An immune-mediated inflammatory disease. Quality of life (QOL) serves as a sensitive measure to evaluate a patient's health status after receiving treatment and assessing the overall impact of the treatment on their well-being. Aim: the survey was n proposed to estimate the quality of life of a group of persons who have Psoriasis, also for explore potential connections between different components of quality of life (such as physical, psychological, social, and environmental health) and specific factors related to the patients. Method: A 50 patients with Psoriasis are included in the study. The world health Organizations quality of life assessment (WHOQOL-BREEF), short style questionnaire was used to evaluate quality of life after being revised and transformed to regional Arabic language. the patients were selected based on their accessibility and availability to the researchers. The mean age of the patients in the study was ( 32.98 ± 6.209). The study was conducted at AL Hussein Teaching Hospital / dermatology department in thi-qar city between November 2023 to March 2024. The questionnaire covers four main domains (26 questions ): Physical Health, Psychological Well-being, Social Relationships, Environmental domain, Each domain contains several questions that collectively measure that specific aspect of quality of life. Result: The response rate was 100 %. Female were 32 while 18 were males. For overall QOL, Very poor (34%), Poor (62%) and Neither poor nor good (4%). For physical activity domain (Mean =.35 ± 4.79) ; and the social health domain (Mean = 21.00 ± 14.60), Psychological health (35.58 ± 3.38 ), Environmental health (44.31 ± 11.23). The total mean score was 36.31, as described as poor. In univariate analysis, age was inversely correlated with both QOL-psychological health and QOL-social health. Gender was inversely associated with all components of QOL except psychological health, where there was no correlation. Furthermore, Higher education levels were inversely associated with all components of QOL except social health, where there was no correlation. In multivariate analysis, only the age was inversely linked to psychological domain. Educational level were inversely linked to physical and psychological health. Gender was inversely linked to all components of QOL except psychological health, where there was no correlation. In Conclusion: QOL of Psoriasis patients with were poor and this condition influence social domain by the first degree, psychological activity and environmental domains are also slightly affected, the physical health domain is slightly affected. Also, It was concluded that in patients with psoriasis, age have inverse relationship with psychological health, Education level have inverse relationship with physical and psychological health, Gender have inverse relationship with all components of QOL except psychological health, where there was no correlation.

References

Baiez YK, Mohammed WK, Interventional Program on Nurses Practices Regarding Burn Wound Dressing, Pakistan Journal of Medical & Health Sciences, 2022, 18;16(05):670

Setoyama A, Sawada Y, Saito-Sasaki N, Ohmori S, Omoto D, Yamamoto K, Yoshioka H, Okada E, Nakamura M., Psoriasis epidemiology screening tool (PEST) is useful for the detection of psoriatic arthritis in the Japanese population, Scientific Reports, 2021; 9;11(1):1-7.

Raharja. A, Mahil, Barker J. N, Psoriasis: a brief overview, Clinical Medicine, 2021; 21(3):170-173.

Bowcock AM, Barker JN, Genetics of psoriasis: the potential impact on new therapies, J Am Acad Dermatol, 2003;49(2 Suppl):1–6.

Nestle FO, Kaplan DH, Barker J, Mechanisms of disease: psoriasis, N Engl J Med, 2009;361(5):496- 509.

Sfikakis PP, Iliopoulos A, Elezoglou A, Kittas C, Stratigos A, Psoriasis induced by anti–tumor necrosis factor therapy: A paradoxical adverse reaction. Arthritis Rheumatism, 2005;52:2513‑8.

Dopytalska K, Sobolewski P, Błaszczak A, Szymańska E, Walecka I., Psoriasis in special localizations, Reumatologia, 2018; 56(6):392-398.

Okamoto F, Umebayasi Y, Ohtsuka F, Hommura S, Factors associated with increased aqueous flare in psoriasis, Jpn J Ophthalmol, 2001;45:172‑6. Campanati A, Neri P, Giuliodori K, Arapi I, Carbonari G, Borioni E, Psoriasis beyond the skin surface: A pilot study on the ocular involvement, Int Ophthalmol, 2015;35:331‑40.

Van De, Kerkhof PCM, Papulosquamous and Eczematous dermatoses: Psoriasis, Dermatology, Edinburg: Mosby; 2003; 125–49.

Cruickshank R, Medical microbiology; a guide to diagnosis and control of infection, Ediburg; London: E and S Livingston Ltd, 1965, 888-889.

Ellen JB, Sydney MF, Baily & Scott‟s diagnostic microbiology, USA, Missouri, 190, 453.

Harsh M, Textbook of Pathology, Medical Publisher Ltd. New Delhi, 5th ed, 2005, 802-803.

Kaine J, Song X, Kim G, Hur P, Palmer JB, Higher incidence rates of comorbidities in patients with psoriatic arthritis compared with the general population using US administrative claims data, J Manag Care Spec Pharm, 2019 ;25(1):122-32.

Soyland E, Funk J, Rajka G, Sandberg M, Thune P, Rustad L, Helland S, Middelfart K, Odu S, Falk ES, Effect of dietary supplementation with very-long-chain n-3 fatty acids in patients with psoriasis, N Engl J Med, 1993, 328:1812-1816.

Kurpet K, Chwatko G, S100 proteins as novel therapeutic targets in psoriasis and other autoimmune diseases, Molecules, 2022, 27(19), 6640.‏

Brown AC, Hairfield M, Richards DG, McMillin DL, Mein EA., Nelson CD, Medical nutrition therapy as a potential complementary treatment for psoriasis--five case reports, In Altern Med Rev, 2004, 9(3):297-307.

Gupta AK, Ellis CN, Tellner DC, Anderson TF, Voorhees JJ, Doubleblind, placebo-controlled study to evaluate the efficacy of fish oil and low dose UVB in the treatment of psoriasis, In Br J Dermatol, 1989, 120:801-807.

Wolters M. (2005). Diet and psoriasis: experimental data and clinical evidence. Br J Dermatol, 153:706-714.

Farquhar M. Definitions of quality of life: A taxonomy. Journal of Advanced Nursing, 1995; 22 (3): 502-508.

Dehghan A, Ghaem H, Borhani Haghighi A, Kashﬁ SM, Zeyghami B, Comparison of quality of life in Parkinson’s patients with and without fatigue, BimonthJHormozganUnivMedSci, 2011;15(1):49–55.

Leila T, Azizallah D, Archive of SID Compare the Quality of Life in Type 2 Diabetic Patients with Healthy Individuals ( Application of WHOQOL-BREF ) Archive of SID, Zahedan J Res Med Sci, 2017; 19(2):5882.

Dehvan F, Saeed DM, Dehkordi AH, Gheshlagh RG, Quality of life of Iranian patients with type 2 diabetes: A systematic review and meta-analysis, Nursing Practice Today, 2019

Apalla Z, Nikolaou V, Fattore D, Fabbrocini G, Freites‐Martinez A , Sollena P, Sibaud, V, European recommendations for management of immune checkpoint inhibitors‐derived dermatologic adverse events. The EADV task force ‘Dermatology for cancer patients’ position statement, Journal of the European Academy of Dermatology and Venereology,2022, 36(3), 332-350.‏

Pearce DJ, Singh S, Balkrishnan R, Kulkarni A, Fleischer AB, Feldman SR, The negative impact of psoriasis on the workplace, J Dermatolog, 2006, 17:2

Apalla Z, Nikolaou V, Fattore D, Fabbrocini G, Freites‐Martinez A, Sollena P, Sibaud V, European recommendations for management of immune checkpoint inhibitors‐derived dermatologic adverse events, The EADV task force ‘Dermatology for cancer patients’ position statement, Journal of the European Academy of Dermatology and Venereology, 2022, 36(3), 332-350

‏Seng KT, Nee ST, Group therapy: a useful and supportive treatment for psoriasis patients, Int J Dermatol, 1997, 36:110-112

Ginsburg IH, Link BG, Psychosocial consequences of rejection and stigma feelings in psoriasis patients, Int J Dermatol, 1993, 32:587-591.

Weiss SC, Kimball AB, Liewehr DJ, Blauvelt A, Turner ML, Emanuel EJ, Quantifying the harmful effects of psoriasis on healthrelated quality of life, J Am Acad Dermatol, 2002, 4:512-518.

Nast A, Smith C, Spuls PI, Avila Valle, G, Bata‐Csörgö, Z, Boonen H, Dressler C, EuroGuiDerm Guideline on the systemic treatment of Psoriasis vulgaris–Part 2: specific clinical and comorbid situations. Journal of the European Academy of Dermatology and Venereology, 2021, 35(2), 281-317.‏

Devrimci-Ozguven H, Kundakci TN, Kumbasar H, Boyvat A, The depression, anxiety, life satisfaction and affective expression levels in psoriasis patients, J Eur Acad Dermatol Venereol, 2000, 14:267-271.

Esposito M, Saraceno R, Giunta A, Maccarone M, Chimenti S, An Italian study on psoriasis and depression, Dermatology, 2006, 212:123-127.

NJ, Gupta AK, Kirkby S, Ellis CN, Suicidal ideation in psoriasis, Int J Dermatol, 1993, 32:188-190

Krueger G, Koo J, Lebwohl M, Menter A, Stern RS, Rolstad T, The impact of psoriasis on quality of life: results of a 1998 National Psoriasis Foundation patient-membership survey., Arch Dermatol 2001, 137:280-284)

Fortune DG, Main CJ, O'Sullivan TM, Griffiths CE, Quality of life in patients with psoriasis: the contribution of clinical variables and psoriasis-specific stress, Br J Dermatol, 1997, 137:755-760.

Maul JT, Augustin M, Sorbe C, Conrad C, Anzengruber F, Mrowietz U, Navarini A, Association of sex and systemic therapy treatment outcomes in psoriasis: a two‐country, multicentre, prospective, noninterventional registry study, British Journal of Dermatology, 2021, 185(6), 1160-1168.‏

Sendrasoa FA, Razanakoto NH, Ratovonjanahary V, Raharolahy O, Ranaivo IM, Andrianarison M, Rapelanoro RF, Quality of life in patients with psoriasis seen in the Department of Dermatology, Antananarivo, Madagascar, BioMed Research International, 2020 (1), 9292163.‏

Chen Y, Wei L, Song. Y, Zhang R, Kuai L, Li B, Wang R, Life quality among psoriasis patients based on Dermatology Life Quality Index evaluation and its association with psoriasis severity in China: a cross-sectional study, Annals of Medicine, 2023, 55(1), 2231847.‏.8200